Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RPRXRPRX
Showing 8 of 24 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ROYALTY PHARMA PLC

GEODE CAPITAL MANAGEMENT, LLC holds 7.9M shares of RPRX (ROYALTY PHARMA PLC), worth $376.5M as of 2026-Q1. The position was increased (+1.9% shares). RPRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$376.5M

Current Shares

7.9M

Total Value Change

+$196.2M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
7.9M
+1.9%
$376.5M0.0%$47.48
32
2025-Q4
Increased
7.7M
+1.3%
$297.5M0.0%$38.99
31
2025-Q3
Decreased
7.6M
-6.8%
$268M0.0%$35.05
0
2025-Q2
Increased
8.2M
+2.2%
$299.5M0.0%$35.46
32
2025-Q1
Increased
8M
+9.4%
$253.5M0.0%$30.80
34
2024-Q4
Increased
7.3M
+0.6%
$186.8M0.0%$24.70
31
2024-Q3
Increased
7.3M
+6.1%
$205.6M0.0%$27.29
33
2024-Q2
Increased
6.8M
+4.6%
$180.3M0.0%$25.32
32

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used